Illumina

Staff Visual Designer

Quebec, Quebec, Canada

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Requirements

The Senior Interaction Designer should possess a strong understanding of user experience principles and design processes, with a passion for building products that improve human health by unlocking the power of the genome. Experience with desktop, web, and mobile application design is essential, as is the ability to understand user personas, use cases, goals, and pain points to deliver quality products and features.

Responsibilities

The Senior Interaction Designer will be responsible for identifying, designing, and optimizing end-to-end user workflows across a variety of projects, leveraging design-led innovation, collaboration, and a user-centered design process to create intuitive and delightful experiences for Illumina’s genomic solutions, ultimately helping scientists and clinicians around the globe make life-changing advances.

Skills

User-Centered Design
Desktop Design
Web Design
Mobile Design
User Personas
Use Cases
Design Principles
Workflow Optimization
Creative Problem Solving
Collaboration

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI